The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated•Originally published 4 May 2026•Updated 4 May 2026•

1 min read

Kornitzer Capital Management Initiates New Positions in REGN and TRV

Key Facts

1Kornitzer Capital Management acquired 1,891 shares in Regeneron Pharmaceuticals, Inc. valued at approximately $1.46 million.

2The investment firm purchased 3,486 shares in The Travelers Companies, Inc. valued at approximately $1.01 million.

3Regeneron reported a 19% year-over-year revenue increase and a $3 billion share buyback program.

Kornitzer Capital Management initiated new equity positions in Regeneron Pharmaceuticals (REGN) and The Travelers Companies (TRV) during the fourth quarter, acquiring 1,891 and 3,486 shares respectively. Conversely, the firm significantly reduced its exposure elsewhere, selling ,6560 shares of MarketAxess Holdings (MKTX) and retaining only 1,314 shares. Ownership in Seagate Technology (STX) was also trimmed, ending the quarter at 2,175 shares. These portfolio adjustments follow a robust period for Regeneron, which reported a 19% revenue increase and a $3 billion share buyback program. The shift suggests a strategic reallocation of capital from technology and financial services toward healthcare and insurance. Institutional moves of this scale are closely watched by market participants as indicators of shifting sentiment in large-cap equities.

about 1 month ago

Version History

Version 1about 1 month ago

What changed: Added details on significant stake reductions in MarketAxess Holdings and Seagate Technology to provide a comprehensive view of portfolio activity.